Vor Biopharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vor Biopharma and other ETFs, options, and stocks.

About VOR

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies.

CEO

Bob Ang

CEOBob Ang

Employees

159

Employees159

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2015

Founded2015

Employees

159

Employees159

VOR Key Statistics

Market cap

95.78M

Market cap95.78M

Price-Earnings ratio

-0.45

Price-Earnings ratio-0.45

Dividend yield

—

Dividend yield—

Average volume

245.36K

Average volume245.36K

High today

$0.8496

High today$0.8496

Low today

$0.7496

Low today$0.7496

Open price

$0.753

Open price$0.753

Volume

330.51K

Volume330.51K

52 Week high

$1.87

52 Week high$1.87

52 Week low

$0.49

52 Week low$0.49

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

Vor Biopharma

Why Robinhood?

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. Show more

VOR Key Statistics

Analyst ratings

100%

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies.